期刊文献+

血管内皮生长因子对恶性腹腔积液诊断价值的Meta分析 被引量:3

Diagnostic Value of Vascular Endothelial Growth Factor in Differentiation of Malignant Ascites: A Meta-analysis
原文传递
导出
摘要 目的系统评价血管内皮生长因子(VEGF)在恶性腹腔积液鉴别诊断中的价值。方法计算机检索MEDLINE、EMbase、Cochrane Library、OVID循证医学数据库及中国期刊网、维普、万方等数据库,查找有关VEGF在恶性腹腔积液鉴别诊断价值的文献,检索时间从1990年1月至2009年12月。采用QUADAS工具评价纳入文献质量,应用Meta-Disc 1.4软件对纳入研究进行综合定量评价,并绘制SROC曲线,对诊断性试验的准确性进行评估。结果共纳入7篇文献。血管内皮生长因子对恶性腹腔积液的鉴别诊断价值分别为:合并敏感度81%[95%CI(0.75,0.85)],合并特异度90%[95%CI(0.86,0.94)],DOR 50.45[95%CI(28.37,89.73)],SROC曲线下面积(AUC)0.9507(SE=0.0130),Q=0.8914(SE=0.0176)。本研究还对人种、试剂来源进行了亚组分析,其中VEGF试剂盒购自R&D公司的3个研究(χ2=0.05,P=0.9750;I2=0.0%)同质性较好,AUC=0.9675(SE=0.0167)。结论经SROC曲线证实,血管内皮生长因子在恶性腹腔积液鉴别诊断中具有较高的敏感度和特异度,可作为重要的筛查和诊断指标。 Objective To establish the overall diagnostic accuracy of the measurements of vascular endothelial growth factor(VEGF) for malignant ascites.Methods After a systematic review of current studies,sensitivity,specificity,and other measures of the value of ascites concentrations of VEGF in the diagnosis of malignant ascites were pooled by using random effects models.Qualified studies on evaluation of VEGF in diagnosis of malignant ascites in English and Chinese published from January 1990 to December 2009 were retrieved from The Cochrane Library,Cochrane Central Register of Controlled Trials,MEDLINE,EMbase,China National Knowledge Infrastructure(CNKI) databases,WanFang Data,and VIP Information.Two reviewers independently assessed the methodological quality of each study with the tool of QUADAS.Statistical analyses were performed by employing Meta-Disc 1.4 software.Meta-analyses of the reported sensitivity and specificity of each study and Summary Receiver Operating Characteristic(SROC) curve were performed.Results Seven studies met the inclusion criteria for the analysis.After testing the heterogeneity of the included studies,a random effect model was selected to calculate the pool weighted sensitivity and specificity with 95% confidence interval: the sensitivity was 0.81(95%CI 0.75 to 0.85),the specificity was 0.90(95%CI 0.86 to 0.94),the DOR was 50.45(95%CI 28.37 to 89.73),and the AUC of SROC was 0.9507(SE=0.0130).The subgroups were analyzed to identify the sources of heterogeneity according to race and agent sources.There was homogeneity among the three studies with agents from RD company(χ2=0.05,P=0.9750;I2=0.0%),and the AUC of SROC were 0.9675(SE=0.0167).Conclusion VEGF has a highly accurate sensitivity and specificity with a strong ROC curve,which makes it a new marker to differentiate malignant ascites from the benign.
出处 《中国循证医学杂志》 CSCD 2011年第2期220-225,共6页 Chinese Journal of Evidence-based Medicine
关键词 血管内皮生长因子 恶性腹腔积液 鉴别诊断 META分析 Vascular endothelial growth factor Malignant ascites Differential diagnosis Meta analysis
  • 相关文献

参考文献13

二级参考文献122

  • 1沈忠海,马红松.腹水中VEGF水平检测在良恶性腹水鉴别诊断中的价值[J].中国卫生检验杂志,2006,16(5):602-603. 被引量:9
  • 2Yasuda S, Afii S, Moil A, et al . Hexokinase Ⅱ and VEGF expressionin liver tumors : correlation with hypoxia-inducible factor-1 alpha and its significance [ J]. J Hepato1,2004 ;40 (1) :117-123. 被引量:1
  • 3Zhong H, DeMarzo AM, Laughner E, et at. Overexpression of hypoxia-inducible factor-1 alpha in common human cancers and their metastases[ J]. Cancer Res,1999,59(22) :5830 - 5835. 被引量:1
  • 4Li L, Lift X, Stayer M, et al. Evaluating hypexia-indueible factor- 1 alpha as a cancer therapeutic target via inducible RNAintefference in vivo[J]. Cancer Res,2005,65(16) :7249-7258. 被引量:1
  • 5Palayoor ST, Mitchell JB, Cerna D, et, al. PX-478, .an inhibitor of hypoxia-inducible factor-1 alpha, enhances radiosensitivity of prostate carcinoma cells[ J]. Int J Cancer,2008,123 ( 10 ) :2430-2437. 被引量:1
  • 6Takeda A, Shimada H,Imaseki H,et al. Clinical significance of serum vascular endothelial growth factor in colorectal cancer patients:correlation with clinieopathological factors and tumor markers[J]. Oncol Rep,2000,7(2):333-338. 被引量:1
  • 7Karayiannakis AJ, Syrigos KN, Polychronidis A, et al. Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgery[J].Ann Surg, 2002,236 (1) : 37- 42. 被引量:1
  • 8Mesiano S, Ferrara N, Jafe RB. Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites form ation by immunoneutralization[J]. Am J Pathol, 1998,153(4) ; 1249- 1256. 被引量:1
  • 9Shibuya M, Luo JC, Toyoda M, et al. Involvement of VEGF and its receptors in ascites tumor formation [J]. Cancer Chemother Pharmacol, 1999,43(Suppl) :S72-77. 被引量:1
  • 10Nascimento I,Schaer R, Lemaire D, et al. Vascular endothelial growth factor (VEGF) levels as a tool to discriminate between malignant and nonmalignant ascites[J]. APMIS, 2004,112 (9) 585-587. 被引量:1

共引文献154

同被引文献18

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部